
HPRA issue serious warning over ‘dangerous risks’ as sale of semaglutide products skyrockets online
“It’s alarming to see consumers willing to take such dangerous risks to their health” The Health Products Regulatory Authority (HPRA) has issued a serious warning to the public about the dangers of buying GLP-1 medicines, such as semaglutide, liraglutide, and tirzepatide, from unregulated and illegal suppliers. These medications, often marketed as weight-loss aids under names […]










